C.M. Bidwell & Associates’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-156	Closed	-$19K	–	397
2018 Q3	$19K	Hold	156	–	–	0.02%	285
2018 Q2	$23K	Buy	+156	New	+$23K	0.02%	289